The Financial Accounting Resource Center™ is a comprehensive research service that provides the full text of standards, the latest news from the Accounting Policy & Practice Report ®,...
Constituents of the International Accounting Standards Board mainly have endorsed the requirements in International Financial Reporting Standard 13: Fair Value Measurement—a major tool for assessing liabilities, equities and financial instruments held by a broad array of industries.
The IASB at its Jan. 18 meeting discussed for the first time the post-implementation review (PIR) of IFRS 13, which a notice on IASB’s website said is designed to assess the impacts of the standard’s new requirements on investors, preparers and auditors.
“Overall, many stakeholders noted that they thought IFRS 13 was working well and has brought in significant improvements to financial reporting,” a staff paper drafted for the meeting said.
IFRS 13—which is largely converged with the U.S. Financial Accounting Standard Board’s ASC 820—sets out provisions for fair value measurements (FVMs) by:
“Rather, the measurement and disclosure requirements of IFRS 13 apply when another IFRS Standard requires or permits an item to be measured at fair value,” with some exceptions, the staff paper said.
An IASB project team conducted about 30 meetings in 2016 that garnered feedback from preparers, auditors, investors, standard setters and regulators as part of phase 1 of the IFRS 13 PIR, staff said.
The project team also met with such IASB advisory panels as the Global Preparers Forum, the Capital Markets Advisory Committee (CMAC)—a sounding board for investors—and the Emerging Economies Group (EEG), which comprises accounting professionals from developing countries.
“Some stakeholders gave specific examples of improvements they have seen since IFRS 13 came into effect, relating to consistency of measurement and disclosures provided,” according to the paper.
IASB constituents, however, also cited problems with the standard.
Some CMAC members, for instance, complained about boilerplate disclosures in accounting practice, and EEG preparers and standard setters from Asia pointed to different approaches that entities take in applying IFRS 13 to the produce of bearer plants.
Board member Mary Tokar during the meeting questioned whether criticisms of IFRS 13 are based in the standard’s provisions or how they’re being put into practice.
“It’s hard to unpick whether what we’ve written is the issue or the application of it,” Tokar said.
IASB Vice-Chairwoman Sue Lloyd suggested that the board consider encouraging other accountancy organizations to draft materials on the standard.
All 12 board members in attendance voted to move to phase 2 of the PIR.
Members voted 11-1 in phase 2 to tackle four problems with IFRS 13 that constituents have underscored, focusing on:
The board also approved, with one member dissenting, to consider whether additional educational materials are needed for measuring the fair value of biological assets and unquoted equity instruments.
In addition, IASB in an 11-1 vote directed staff to publish a request for information on the four problems—disclosure effectiveness, quoted investments, judgment application and HBU—that stakeholders identified during phase 1.
Staff said they’re not ready yet to recommend potential changes to the standard.
Looking ahead, Tokar urged the board to carry out a thorough evaluation of IFRS 13 but to avoid responding to trivial critiques of the standard.
“We should focus in the PIR on urgent matters rather than completely capturing every criticism,” she said.
To contact the reporter on this story: David R. Jones in London at firstname.lastname@example.org
To contact the editor responsible for this story: S. Ali Sartipzadeh at email@example.com
Papers drafted for the meeting are available at http://www.ifrs.org/Meetings/Pages/IASB-Meeting-January-2017.aspx.
Copyright © 2017 Tax Management Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)